Bridge Technology with TSH Receptor Chimera for Sensitive Direct Detection of TSH Receptor Antibodies Causing Graves' Disease: Analytical and Clinical Evaluation

Hormone and Metabolic Research

Volumn 47, Issue 12, 2015, Pages 880-888

  Frank, C U ^a   Braeth, S ^a   Dietrich, J W ^b   Wanjura, D ^c   Loos, U ^a  

^a KreLo GmbH Medical Diagnostics   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Gemeinschaftspraxis Radiologie and Nuklearmedizin   (Germany)

Author keywords

bridge assay; graves' disease; thyroid stimulating autoantibodies; TSH receptor

Indexed keywords

THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; AUTOANTIBODY;

ANTIBODY TITER; ARTICLE; BIOASSAY; BRIDGE ASSAY; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOCRINE OPHTHALMOPATHY; EYE DISEASE; FALSE NEGATIVE RESULT; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROXINE BLOOD LEVEL; BLOOD; CHIMERA; IMMUNOLOGY;

AUTOANTIBODIES; CHIMERA; GRAVES DISEASE; HUMANS; RECEPTORS, THYROTROPIN; SENSITIVITY AND SPECIFICITY; THYROXINE;

EID: 84946476948     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0035-1554662     Document Type: Article

References (45)

1. Weetman A. P. Graves' disease. N Engl J Med: 2000; 343 1236 1248
2. Prabhakar B. S., Bahn R. S., Smith T. J. Current perspective of the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev: 2003; 24 802 835
3. Bartalena L. Diagnosis and management of Graves' disease: a global overview. Nat Rev Endocrinol: 2013; 9 724 734
4. th edition New York McGraw Hill: 2008; 2233
5. Abraham-Nordling M., Byström K., Törring O., Lantz M., Berg G., Calissendorff J., Nyström H. F., Jansson S., Jörneskog G., Karlsson F. A., Nyström E., Ohrling H., Orn T., Hallengren B., Wallin G. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol: 2011; 165 899 905
6. Johns Hopkins Medical Institutions Autoimmune Disease Research Center. Information on Graves' disease. Available at http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&diseaseID=21 Accessed 18 July: 2014
7. Shewring G., Smith B. R. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf): 1982; 17 409 417
8. Costagliola S., Morgenthaler N. G., Hoermann R., Badenhoop K., Struck J., Freitag D., Poertl S., Weglöhner W., Hollidt J. M., Quadbeck B., Dumont J. E., Schumm-Draeger P. M., Bergmann A., Mann K., Vassart G., Usadel K. H. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab: 1999; 84 90 97
9. Gassner D., Stock W., Golla R., Roth H. J. First automated assay for thyrotropin receptor autoantibodies. Clin Chem Lab Med: 2009; 47 1091 1095
10. Vitti P., Valente W. A., Ambesi-Impiombato F. S., Fenzi G. F., Pinchera A., Kohn L. D. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. J Endocrinol Invest: 1982; 5 179 182
11. Giuliani C., Cerrone D., Harii N., Thornton M., Kohn L. D., Dagia N. M., Fiore E., Bucci I., Chamblin T., Vitti P., Monaco F., Napolitano G. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease. J Clin Endocrinol Metab: 2012; 97 E1106 E1115
12. Lytton S. D., Ponto K. A., Kanitz M., Matheis N., Kohn L. D., Kahaly G. J. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. J Clin Endocrinol Metab: 2010; 95 2123 2131
13. Diana T., Kanitz M., Lehmann M., Li Y., Olivo P. D., Kahaly G. J. Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies. Thyroid: 2015; 25 169 175
14. Araki N., Iida M., Amino N., Morito S., Ide A., Nishihara E., Ito M., Saito J., Nishikawa T., Katsuragi K., Miyauchi A. Rapid bioassay for the detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. Eur Thyroid J: 2014; 4 14 19
15. 125I-labeled human thyrotropin receptor and its use for the detection of pathological autoantibodies in sera from Graves' patients. J Endocrinol: 1999; 160 239 245
16. Minich W. B., Loos U. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Exp Clin Endocrinol Diabetes: 2000; 108 110 119
17. Chazenbalk G. D., Pichurin P., McLachlan S. M., Rapoport B. A direct binding assay for thyrotropin receptor autoantibodies. Thyroid: 1999; 9 1057 1061
18. Sanders J., Oda Y., Roberts S., Kiddie A., Richards T., Bolton J., McGrath V., Walters S., Jaskólski D., Furmaniak J., Smith B. R. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. J Clin Endocrinol Metab: 1999; 84 3797 3802
19. Loos U., Franz C., Minich W. B., Büsselmann I. Direct assay of TSH receptor autoantibodies causing Graves' disease correlates with the clinical diagnosis closer than assays on TSH displacement. Horm Res: 2007; 68 03 21 29
20. Rees Smith B., Sanders J., Evans M., Tagami T., Furmaniak J. TSH receptor-autoantibody interactions. Horm Metab Res: 2009; 41 448 455
21. Tahara K., Ishikawa N., Yamamoto K., Hirai A., Ito K., Tamura Y., Yoshida S., Saito Y., Kohn L. D. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid: 1997; 7 867 877
22. Rapoport B., Chazenbalk G. D., Jaume J. C., McLachlan S. M. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev: 1998; 19 673 716
23. Tahara K., Ban T., Minegishi T., Kohn L. D. Immunoglobins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras then either TSH or immunoglobins from idiopathic myxedema patients. Biochem Biophys Res Commun: 1991; 179 70 77
24. McFarland K. C., Sprengel R., Phillips H. S., Köhler M., Rosemblit N., Nikolics K., Segaloff D. L., Seeburg P. H. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science: 1989; 245 494 499
25. Loos U., Schmitt T., Frank C., Büsselmann I. Development of a novel bioassay for the detection of thyroid-stimulating autoantibodies in Graves' disease (GD) facilitating routine measurement by reduced handling steps and high stability of cAMP monitoring reagent. Poster presentation at the ITC Paris: 2010; P-0020 Available at https://b-com.mci-group.com/AbstractList/ITC2010.aspx
26. Bahn R. S., Burch H. B., Cooper D. S., Garber J. R., Greenlee M. C., Klein I., Laurberg P., McDougall I. R., Montori V. M., Rivkees S. A., Ross D. S., Sosa J. A., Stan M. N. American Thyroid Association; American Association of Clinical Endocrinologists Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists. Endocr Pract: 2011; 17 e1 e65
27. European Group on Graves' Orbitopathy (EUGOGO) Wiersinga W. M., Perros P., Kahaly G. J., Mourits M. P., Baldeschi L., Boboridis K., Boschi A., Dickinson A. J., Kendall-Taylor P., Krassas G. E., Lane C. M., Lazarus J. H., Marcocci C., Marino M., Nardi M., Neoh C., Orgiazzi J., Pinchera A., Pitz S., Prummel M. F., Sartini M. S., Stahl M., von Arx G. Clinical assessment of patients with Graves' orbitopathy: the EUGOGO recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol: 2006; 155 387 389
28. NCCLS document EP5-A Evaluation of precision performance of clinical chemistry devices; approved guideline. Wayne PA Clinical and Laboratory Standards Institute: 1999
29. R development core team, 2009 R: A language and environment for statistical computing; R foundation for statistical computing; Vienna, Austria. Availabvle at http://R-project.org
30. Morgenthaler N. G., Minich W. B., Willnich M., Bogusch T., Hollidt J. M., Weglohner W., Lenzner C., Bergmann A. Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum. Mol Cell Endocrinol: 2003; 212 73 79
31. Nakatake N., Sanders J., Richards T., Burne P., Barrett C., Dal Ora C., Presotto F., Betterle C., Furmaniak J., Rees Smith B. Estimation of serum TSH receptor autoantibody concentration and affinity. Thyroid: 2006; 16 1077 1084
32. Bahn R., Levy E., Wartofsky L. Graves' disease. J Clin Endocrinol Metab: 2007; 92 2p following 14A
33. Eckstein A., Plicht M., Lax H., Neuhäuser M., Mann K., Lederbogen S., Heckmann C., Esser J., Morgenthaler N. G. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophtalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab: 2006; 91 3464 3470
34. Evans M., Sanders J., Tagami T., Sanders P., Young S., Roberts E., Wilmot J., Hu X., Kabelis K., Clark J., Holl S., Richards T., Collyer A., Furmaniak J., Smith B. R. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol: 2010; 73 404 412
35. Sanders P., Young S., Sanders J., Kabelis K., Baker S., Sullivan A., Evans M., Clark J., Wilmot J., Hu X., Roberts E., Powell M., Nunez Miguel R., Furmaniak J., Smith B. R. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol: 2011; 46 81 99
36. Li Y., Kim J., Diana T., Klasen R., Olivo P. D., Kahaly G. J. A novel bioassay for anti-thyrotropin autoantibodies detects both thyroid-blocking and stimulating activity. Clin Exp Immunol: 2013; 173 390 397
37. Minich W. B., Lenzner C., Bergmann A., Morgenthaler N. G. A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies. J Clin Endocrinol Metab: 2004; 89 352 356
38. Grasso Y., Kim M. R., Faiman C., Kohn L. D., Tahara K., Gupta M. K. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. Thyroid: 1999; 9 531 537
39. Morgenthaler N. G., Ho S. C., Minich W. B. Stimulating and Blocking Thyroid-Stimulating Hormone (TSH) Receptor Autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. J Clin Endocrinol Metab: 2007; 92 1058 1065
40. Ando T., Latif R., Daniel S., Eguchi K., Davies T. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology: 2004; 14 5185 5193
41. Giuliani C., Cerrone D., Harii N., Thornton M., Kohn L. D., Dagia N. M., Bucci I., Carpentieri M., Di Nenno B., Di Blasio A., Vitti P., Monaco F., Napolitano G. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment. J Clin Endocrinol Metab: 2012; 97 E1080 E1087
42. nd generation TSH receptor autoantibody measurements. Clin Lab: 2008; 54 243 249
43. Schott M., Morgenthaler N. G., Fritzen R., Feldkamp J., Willenberg H. S., Scherbaum W. A., Seissler J. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. Horm Metab Res: 2004; 36 92 96
44. Eckstein A., Mann K., Kahaly G. J., Grussendorf M., Reiners C., Feldkamp J., Quadbeck B., Bockisch A., Schott M. Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophtalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology. Med Klin (Munich): 2009; 104 343 348
45. Carella C., Mazziotti G., Sorvillo F., Piscopo M., Cioffi M., Pilla P., Nersita R., Iorio S., Amato G., Braverman L. E., Roti E. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid: 2006; 16 295 302